Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101

PHASE3CompletedINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

January 31, 2016

Study Completion Date

August 31, 2016

Conditions
Submental FatHealthy
Interventions
DRUG

ATX-101

Clinical evaluation, patient reported outcome questionnaires, photographs, caliper measurements, recording of adverse events

DRUG

Placebo

Clinical evaluation, patient reported outcome questionnaires, photographs, caliper measurements, recording of adverse events

Trial Locations (15)

20769

Callender Center for Clinical Research, Glendale

20850

Aesthetics, Skin Care, Dermatologic Surgery, Rockville

33137

Baumann Cosmetic and Research Center, Miami

33146

Dermatology Research Institute, Coral Gables

Stephan Baker MD PA, Coral Gables

33401

Kenneth R. Beer, MD, PA, West Palm Beach

37215

Tennessee Clinical Research Center, Nashville

60005

Altman Dermatology Associates, Arlington Hts

60563

DuPage Medical Group, Dermatology Institute, Naperville

60611

DeNova Research, Chicago

75093

Research Across America, Plano

80113

AboutSkin Dermatology and DermSurgery, PC, Englewood

92121

Dermatology Cosmetic Laser Medical Associates of La Jolla, San Diego

V5Z 4E1

Shannon Humphrey, MD, Vancouver

V5Z4E1

Carruthers Dermatology Centre Inc., Vancouver

Sponsors
All Listed Sponsors
lead

Kythera Biopharmaceuticals

INDUSTRY